Upsetting categories? The consequences of pharmacogenomics for making knowledge-based reimbursement decisions in Sweden

ISSN： 1469-9915

Source： New Genetics & Society, Vol.29, Iss.4, 2010-12, pp. : 389-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Pharmacogenomics: A Value-Based Approach to Pragmatic Decision Making in the Face of Complexity

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-09 ,pp. : 256-264

Karger

Access to resources Recommend Favorite

Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-10 ,pp. : 248-255

Karger

Access to resources Recommend Favorite

Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results

American Journal Of Medical Genetics Part A, Vol. 176, Iss. 2, 2018-02 ,pp. : 376-385

John Wiley & Sons Inc

Access to resources Recommend Favorite

Actionable clinical decisions based on comprehensive genomic evaluation in asymptomatic adults

Molecular Genetics & Genomic Medicine, Vol. 3, Iss. 5, 2015-09 ,pp. : 433-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Actionable clinical decisions based on comprehensive genomic evaluation in asymptomatic adults

Molecular Genetics & Genomic Medicine, Vol. 2324-9269, Iss. 5, 2015-09 ,pp. : 433-439

John Wiley & Sons Inc

Access to resources Recommend Favorite